Propolis from Poland versus propolis from New Zealand - chemical composition and antiproliferative properties on glioblastoma cell lines.
Abstract Background Several studies have previously reported that propolis and its ingredients inhibit glioma cancer cell lines. The chemical composition and antiproliferative activity of propolis from Poland (PPE) and propolis from New Zealand (MPE) were compared in this study. Methods The chemical composition was investigated by gas chromatography-mass spectrometry. Antiproliferative activity of PPE and MPE was determined by a cytotoxicity test and DNA binding by [ 3 H]-thymidine incorporation on Human Diffuse Astrocytoma cell line (DASC) derived from a patient with a Grade II glioma and glioblastoma multiforme T98G and LN-18 cell lines from American Type Culture Collection. Results The chemical composition of both propolis was comparable, with marginal differences in the amount of some compounds. Flavonoids and chalcones, of which pinocembrin, pinobanksin, pinobanksin 3-acetate, chrysin and galangin showed the highest level, were the main components of both examined propolis (PPE–49.4% and MPE–52.1%). The performed cytotoxicity test showed powerful activity of PPE and MPE propolis on DASC, T98G and LN-18 cells. The degree of the antiproliferative activity was similar in the case of both propolis (viability after 72 h for 30 µg/mL ranged from 22.0% to 51.6% and proliferation inhibition after 72 h approximately was from 18.6% to 75.6%). Conclusions These results are the first to show that propolis from Poland and propolis from New Zealand have a strong cytotoxic and antiproliferative effect on DASC (Grade II glioma) derived from a patient and glioblastoma multiforme T98G and LN-18 cell lines. This activity may be associated with the high content of polyphenolic compounds in both propolis. These findings suggest that Polish and New Zealand propolis shows promising anticancer activity in the treatment of glioblastoma. However, further studies are required.